These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27077843)
21. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4. Li Z; Li X; Xu L; Tao Y; Yang C; Chen X; Fang F; Wu Y; Ding X; Zhao H; Li M; Qian G; Xu Y; Ren J; Du W; Wang J; Lu J; Hu S; Pan J Oncol Rep; 2017 Nov; 38(5):2705-2716. PubMed ID: 29048629 [TBL] [Abstract][Full Text] [Related]
22. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745 [TBL] [Abstract][Full Text] [Related]
23. A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion. Wang F; Gao Y; Tang L; Ning K; Geng N; Zhang H; Li Y; Li Y; Liu F; Li F Biochem Biophys Res Commun; 2019 Apr; 511(2):404-408. PubMed ID: 30808546 [TBL] [Abstract][Full Text] [Related]
24. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion. Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167 [TBL] [Abstract][Full Text] [Related]
25. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581 [TBL] [Abstract][Full Text] [Related]
26. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer. Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832 [TBL] [Abstract][Full Text] [Related]
27. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer. Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Tabusa H; Brooks T; Massey AJ Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484 [TBL] [Abstract][Full Text] [Related]
29. P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation. Xie X; Shi X; Guan H; Guo Q; Fan C; Dong W; Wang G; Li F; Shan Z; Cao L; Teng W Oncotarget; 2017 Apr; 8(15):24882-24891. PubMed ID: 28178642 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of p21-activated kinase 4 expression suppresses the proliferation of Hep-2 laryngeal carcinoma cells via activation of the ATM/Chk1/2/p53 pathway. Sun X; Liu B; Wang J; Li J; Ji WY Int J Oncol; 2013 Feb; 42(2):683-9. PubMed ID: 23229348 [TBL] [Abstract][Full Text] [Related]
31. Smilax glabra Roxb targets Akt(p-Thr308) and inhibits Akt-mediated signaling pathways in SGC7901 cells. Hao G; Zheng J; Huo R; Li J; Wen K; Zhang Y; Liang G J Drug Target; 2016; 24(6):557-65. PubMed ID: 26607178 [TBL] [Abstract][Full Text] [Related]
32. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Zhou Y; Su J; Shi L; Liao Q; Su Q Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092 [TBL] [Abstract][Full Text] [Related]
33. A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth. Rane C; Senapedis W; Baloglu E; Landesman Y; Crochiere M; Das-Gupta S; Minden A Sci Rep; 2017 Feb; 7():42555. PubMed ID: 28198380 [TBL] [Abstract][Full Text] [Related]
34. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Ahmed T; Shea K; Masters JR; Jones GE; Wells CM Cell Signal; 2008 Jul; 20(7):1320-8. PubMed ID: 18424072 [TBL] [Abstract][Full Text] [Related]
35. Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy. Hao C; Huang W; Li X; Guo J; Chen M; Yan Z; Wang K; Jiang X; Song S; Wang J; Zhao D; Li F; Cheng M Eur J Med Chem; 2017 May; 131():1-13. PubMed ID: 28284095 [TBL] [Abstract][Full Text] [Related]
36. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer. Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174 [TBL] [Abstract][Full Text] [Related]
37. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Zhang X; Zhang X; Li Y; Shao Y; Xiao J; Zhu G; Li F Cell Death Dis; 2017 May; 8(5):e2820. PubMed ID: 28542136 [TBL] [Abstract][Full Text] [Related]
38. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Yan X; Rui X; Zhang K Oncol Rep; 2015 Feb; 33(2):737-43. PubMed ID: 25502212 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923 [TBL] [Abstract][Full Text] [Related]
40. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation. Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]